PAVM PAVMED INC Delisting Actions 8-K Filing 2025 - Nasdaq Compliance Notice Pavmed Inc. received a notice from Nasdaq for not meeting the $1 minimum bid price for its stock, giving it 180 days to comply, and also sold 2,653 shares of Series C Convertible Preferred Stock for approximately $2.653 million to reduce debt, which could lead to issuing up to 12.4 million shares if converted at the lowest price.Get access to all SEC 8-K filings of the PAVMED INC